Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
RECENTIN did not meet primary endpoint in Horizon III study in metastatic colorectal cancer
-
AstraZeneca Provides An Update On The Status Of Its Arrangements With Merck
-
AstraZeneca Reaches Agreement With UK Tax Authorities Over Transfer Pricing
-
AstraZeneca and Rigel Pharmaceuticals Sign Worldwide License Agreement for Late-Stage Development Product -- Fostamatinib Disodium (R788) -- for the Treatment of Rheumatoid Arthritis
-
US FDA Approves New Indication for Crestor (Rosuvastatin Calcium)
-
AstraZeneca PLC Fourth Quarter and Full Year Results 2009
-
AstraZeneca Reaches Agreements With Teva Pharmaceuticals Regarding Nexium And Prilosec US Patent Litigations
-
MedImmune Replies to FDA Complete Response Letter on Motavizumab
-
AstraZeneca To Acquire Infection Research Company Novexel And Expand Collaboration With Forest Laboratories
-
Favourable Vote From FDA Advisory Committee On Benefit/Risk Of CRESTOR In JUPITER Study
Latest articles and press releases
All of our latest press releases and articles are available to explore